Wacker Chemie AG stock (DE000WCH8881): Key player in silicones and polysilicon

Wacker Chemie AG, a leading supplier of silicones, polymers and polysilicon, continues to serve critical industries worldwide. US investors track its exposure to semiconductors and chemicals amid global supply chain dynamics.

Wacker Chemie AG released its Q1 2026 results on April 30, 2026, reporting EBITDA of €182 million for the period ended March 31, 2026, down from €213 million a year earlier, according to Wacker Chemie press release as of 04/30/2026. The company maintained its full-year guidance, citing stable demand in silicones despite challenges in polysilicon. Shares traded at €85.20 on Xetra on May 13, 2026, reflecting a 1.2% decline over the prior week, per Börse Frankfurt as of 05/13/2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Wacker Chemie AG
• Sector/industry: Chemicals
• Headquarters/country: Germany
• Core markets: Europe, US, Asia
• Key revenue drivers: Silicones, polymers, polysilicon
• Home exchange/listing venue: Xetra (WCH)
• Trading currency: EUR

Wacker Chemie AG: core business model

Wacker Chemie AG specializes in chemical products based on silicon, polymers and biotech. The company operates four business divisions: Wacker Silicones, Polymers, Biosolutions and Polysilicon. Silicones generate the largest share of revenue, used in automotive, construction and electronics. Headquartered in Munich, Germany, it employs around 14,300 people globally as of its 2025 annual report published March 2026.

Polysilicon production supports the solar and semiconductor industries, with plants in Germany, the US and Singapore. Wacker Chemie invested €200 million in US capacity expansion in 2025, enhancing its North American footprint, according to its 2025 annual report as of 03/2026. This positions the firm to benefit from US semiconductor incentives under the CHIPS Act.

Main revenue and product drivers for Wacker Chemie AG

Silicones accounted for 45% of 2025 group sales of €5.75 billion, driven by dispersible polymer powders for dry-mix mortars and silicone elastomers for medical devices. Polymers contributed 20%, with applications in paints and adhesives. Polysilicon sales reached €1.2 billion in 2025, fueled by solar panel demand despite price pressures, per the annual report cited above.

Biosolutions, at 5% of revenue, focuses on fermented proteins and cyclodextrins for food and pharma. Regional breakdown shows 30% of sales from the Americas in 2025, underscoring relevance to US investors via exposure to construction recovery and EV production.

Industry trends and competitive position

The global silicones market is projected to grow at 5.2% CAGR through 2030, per MarketsandMarkets as of 01/2026. Wacker Chemie holds a top-three position alongside Dow and Shin-Etsu. In polysilicon, it competes with OCI and Hemlock, but differentiates via high-purity grades for semiconductors.

US market dynamics favor Wacker through its Tennessee polysilicon site, supplying firms like Intel and TSMC. Energy costs and supply chain resilience remain key factors amid geopolitical tensions.

Why Wacker Chemie AG matters for US investors

Wacker Chemie trades as an ADR (WCWIY) on OTC markets, offering US investors direct access. Its US revenue share exceeds 25%, tied to automotive silicones and solar supply chains. The firm's €150 million capex in Charleston, TN, announced in 2025, aligns with domestic manufacturing pushes.

Q1 2026 results in detail

Group sales fell 8% to €1.65 billion in Q1 2026 from €1.8 billion, with EBITDA margin at 11% versus 11.8%. Polysilicon EBITDA dropped due to lower prices, offset by silicone volume growth. Net debt stood at €1.8 billion as of March 31, 2026, per the earnings release.

Conclusion

Wacker Chemie AG navigates cyclical polysilicon markets while leveraging stable silicone demand. Q1 results met expectations, with guidance intact for 2026 EBITDA of €750-850 million. Investors monitor solar recovery and US expansion for potential upside. The stock's valuation reflects balanced chemical sector dynamics.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.